RU93028213A - METHOD FOR DETERMINING BLOOD SUGAR - Google Patents

METHOD FOR DETERMINING BLOOD SUGAR

Info

Publication number
RU93028213A
RU93028213A RU93028213/14A RU93028213A RU93028213A RU 93028213 A RU93028213 A RU 93028213A RU 93028213/14 A RU93028213/14 A RU 93028213/14A RU 93028213 A RU93028213 A RU 93028213A RU 93028213 A RU93028213 A RU 93028213A
Authority
RU
Russia
Prior art keywords
sugar
blood sugar
determining blood
blood
saliva
Prior art date
Application number
RU93028213/14A
Other languages
Russian (ru)
Inventor
М.Д. Хегай
С.Е. Зайчик
Original Assignee
Санкт-Петербургский санитарно-гигиенический медицинский институт
Filing date
Publication date
Application filed by Санкт-Петербургский санитарно-гигиенический медицинский институт filed Critical Санкт-Петербургский санитарно-гигиенический медицинский институт
Publication of RU93028213A publication Critical patent/RU93028213A/en

Links

Claims (1)

Изобретение относится к биохимическим способам оценки уровня гликемии у человека и может быть использован в широкой клинической практике. С целью упрощения и повышения точности определения сахара в крови без прямого исследования крови определяют сахар в слюне биохимическим методом и по количеству содержащегося в слюне сахара судят об уровне его в крови.The invention relates to biochemical methods for assessing the level of glycemia in humans and can be used in a wide clinical practice. In order to simplify and improve the accuracy of determining blood sugar without direct blood testing, sugar in the saliva is determined by a biochemical method and the level of sugar in the blood is determined by the amount of sugar contained in the saliva.
RU93028213/14A 1993-05-24 METHOD FOR DETERMINING BLOOD SUGAR RU93028213A (en)

Publications (1)

Publication Number Publication Date
RU93028213A true RU93028213A (en) 1996-02-10

Family

ID=

Similar Documents

Publication Publication Date Title
DE3852827D1 (en) BODY LIQUID TEST TO MEASURE BONE RESORPTION.
NO890071D0 (en) DEGREE ANALYSIS FOR COLLAGEN TYPE III.
DE69312513T2 (en) HUMAN CYCLOOXYGENASE-2cDNA AND DETERMINATION OF HUMAN CYCLOOXYGENASE-2 INHIBITION
ES489644A0 (en) A METHOD OF DETERMINING THE QUANTITY OR CONCENTRATION OF AN ANALYTE IN A SAMPLE
DE3788762D1 (en) Method for the determination of physiologically active substances.
DE69029556D1 (en) Dry analytical element for the quantitative analysis of analytes contained in whole blood
FI950507A (en) Assay method for the determination of protein in a biological sample
DE68905313D1 (en) ENZYME IMMUNOASSAY FOR MEASURING CYCLOSPORIN-A MIRRORS IN WHOLE BLOOD SAMPLES.
DK479888A (en) METHOD OF QUANTITATIVE DETERMINATION OF THE QUANTITY OF LITHIUM IN A FLUID SAMPLE
DE68915437D1 (en) METHOD FOR DETERMINING THE TYPE AND DEGREE OF SERIOUS DISEASE CONDITIONS.
RU93028213A (en) METHOD FOR DETERMINING BLOOD SUGAR
DK173884A (en) PROCEDURE FOR QUANTITATIVE DETERMINATION OF THE HAEMOGLOBIN CONCENTRATION IN A BIOLOGICAL TEST
RU95108545A (en) Method and set for detection and estimation of periodontitis development risk
DE69424974D1 (en) Monitoring of colon cancer patients by measuring NCA 50/90 in the blood
SU1714510A1 (en) Method for determination of hormonal dependency in the autoimmune diseases
DE69425394D1 (en) Monitoring patients with lung cancer by measuring NCA 50/90 in the blood
SU1274682A1 (en) Method of diagnosis of salmonollosis of children
DK0587090T3 (en) Method for determining thrombosis-causing lupus anticoagulant antibodies.
SU1175442A1 (en) Method of diagnosis of brain hypoxia of the newborns
RU97101930A (en) METHOD FOR EVALUATING INDIVIDUAL SENSITIVITY OF PATIENTS TO HEMOCONTECT DRUGS FOR HEMOSORPTION PROCEDURES
RU95101284A (en) METHOD FOR DIAGNOSTIC OF INTESTINAL INFARCTION
RU95108344A (en) METHOD FOR ESTIMATING EFFECTIVENESS OF TREATMENT OF ISCHEMIC HEART DISEASE
RU94014977A (en) Method for estimating whole blood serotonin concentration
RU93048487A (en) METHOD FOR DIAGNOSTICS AND METHOD FOR FORECASTING THE COURSE OF DERMATOMYOSIS
PL293162A1 (en) Rapid testing kit for detecting and semi-quantitati vely determining the content of urea in biological fluids, in particular in serum and whole blood, and method of making such kit